{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:08:00Z","timestamp":1792026480192,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2019T103"],"award-info":[{"award-number":["2019T103"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.atherosclerosis.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:26:31Z","timestamp":1684927591000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank"],"prefix":"10.1016","volume":"376","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-809X","authenticated-orcid":false,"given":"Raymond","family":"Noordam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas AG.","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobijn","family":"Gussekloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Mooijaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Willems van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"van Heemst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib1","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.116.026560","article-title":"Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a mendelian randomization analysis","volume":"135","author":"Dale","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamacardio.2016.5804","article-title":"Association of body mass index with cardiometabolic disease in the UK biobank: a mendelian randomization study","volume":"2","author":"Lyall","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamacardio.2019.2202","article-title":"Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study","volume":"4","author":"Nazarzadeh","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archinte.158.6.655","article-title":"Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention","volume":"158","author":"Grover","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","article-title":"An international model to predict recurrent cardiovascular disease","volume":"125","author":"Wilson","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib8","doi-asserted-by":"crossref","first-page":"b2376","DOI":"10.1136\/bmj.b2376","article-title":"The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials","volume":"338","author":"Brugts","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Cholesterol Treatment Trialists","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature14962","article-title":"The UK10K project identifies rare variants in health and disease","volume":"526","author":"Walter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A reference panel of 64,976 haplotypes for genotype imputation","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib20","first-page":"12","article-title":"glm2: fitting generalized linear models with convergence problems","volume":"3","author":"Marschner","year":"2011","journal-title":"RSA J."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib21","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s11357-021-00498-9","article-title":"Classical risk factors for primary coronary artery disease from an aging perspective through Mendelian randomization","volume":"44","author":"Jansen","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40200-020-00557-6","article-title":"Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials","volume":"19","author":"Cordero","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacc.2018.10.039","article-title":"Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial","volume":"73","author":"Szarek","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.amjcard.2009.02.048","article-title":"Meta-analysis of adverse cardiovascular outcomes associated with antecedent hypertension after myocardial infarction","volume":"104","author":"Chen","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/EDE.0000000000001072","article-title":"Survival bias in mendelian randomization studies: a threat to causal inference","volume":"30","author":"Smit","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11906-010-0099-1","article-title":"The obesity paradox and cardiovascular disease","volume":"12","author":"Morse","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib28","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.165.1.55","article-title":"The obesity paradox: body mass index and outcomes in patients with heart failure","volume":"165","author":"Curtis","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib30","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/eurheartj\/ehaa398","article-title":"The obesity paradox in secondary prevention: a weighty intervention or a wait for more evidence?","volume":"41","author":"Sattar","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ije\/dyv031","article-title":"LDL cholesterol still a problem in old age? A Mendelian randomization study","volume":"44","author":"Postmus","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/EDE.0000000000000081","article-title":"Methodological challenges in mendelian randomization","volume":"25","author":"VanderWeele","year":"2014","journal-title":"Epidemiology"},{"key":"10.1016\/j.atherosclerosis.2023.05.011_bib33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2018.2866","article-title":"Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes","volume":"3","author":"Lotta","year":"2018","journal-title":"JAMA Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023002058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023002058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:51:37Z","timestamp":1758156697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":33,"alternative-id":["S0021915023002058"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.011","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}